No evidence for essential differences between the effects of insulin glargine, insulin detemir and NPH [neutral protamine Hagedorn] insulin on glucose metabolism after a single injection as assessed by 24-h euglycemic clamp studies in healthy humans

Trial Profile

No evidence for essential differences between the effects of insulin glargine, insulin detemir and NPH [neutral protamine Hagedorn] insulin on glucose metabolism after a single injection as assessed by 24-h euglycemic clamp studies in healthy humans

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin glargine; Insulin suspension isophane
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Nov 2012 Planned number of patients changed from 10 to 12 as reported by European Clinical Trials Database.
    • 01 Jul 2010 Actual volunteer numbers reported as 10
    • 11 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top